Development of classification criteria for discoid lupus erythematosus: Results of a Delphi exercise

Background No classification criteria currently exist for discoid lupus erythematosus (DLE), which has led to problematic heterogeneity in both observational and interventional research efforts. Objectives We sought to develop DLE classification criteria based on consensus of international expert op...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Academy of Dermatology 2017-08, Vol.77 (2), p.261-267
Hauptverfasser: Elman, Scott A., MD, Joyce, Cara, PhD, Nyberg, Filippa, MD, Furukawa, Fukumi, MD, Goodfield, Mark, MD, Hasegawa, Minoru, MD, Marinovic, Branka, MD, Szepietowski, Jacek C., MD, Dutz, Jan, MD, FRCPC, Werth, Victoria P., MD, Merola, Joseph F., MD, MMSc
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background No classification criteria currently exist for discoid lupus erythematosus (DLE), which has led to problematic heterogeneity in both observational and interventional research efforts. Objectives We sought to develop DLE classification criteria based on consensus of international expert opinion of relevant stakeholders in the field. Methods Using a Delphi consensus process and nominal group techniques, potential items for classification criteria were generated. Experts ranked items in terms of their appropriateness and ability to discriminate DLE from other diagnoses, and items were subsequently eliminated using consensus exercises. Results A final list of 12 clinical and histopathologic items was generated for potential inclusion into a set of DLE classification criteria through a formal ongoing validation process. Limitations The participants are predominantly composed of DLE experts in North America and Europe. Conclusion This work represents a key step toward the development of formal DLE classification criteria.
ISSN:0190-9622
1097-6787
1097-6787
DOI:10.1016/j.jaad.2017.02.030